ALOX15B and colitis: Colonic mucosa from patients with ulcerative colitis produced significantly lower (12-fold) amounts of LXA4 compared with control [52], and mice chronically treated with a selective 15-lipoxygenase inhibitor experienced significantly worse intestinal function during experimental colitis, relative to untreated mice.